In Planta production of immunogenic poliovirus peptide using tobacco mosaic virus-based vector system

Journal of Bioscience and Bioengineering

Volumn 101, Issue 5, 2006, Pages 398-402

  Fujiyama, Kazuhito ^a   Saejung, Wanida ^a   Yanagihara, Itaru ^b   Nakado, Junko ^a   Misaki, Ryo ^a   Honda, Takeshi ^c   Watanabe, Yuichiro ^d   Seki, Tatsuji ^a  

^a OSAKA UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Nicotiana tabacum cv. Samsun; poliovirus; tobacco mosaic virus

Indexed keywords

AMINO ACIDS; ANTIBODIES; ANTIGENS; GENES; IMMUNIZATION; PROTEINS; VACCINES; VIRUSES;

NICOTIANA TABACUM CV. SAMSUN; POLIOVIRUS; TOBACCO MOSAIC VIRUS;

PLANTS (BOTANY);

CAPSID PROTEIN; HYBRID PROTEIN; PROTEIN VP3; RECOMBINANT POLIOVIRUS VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN 1; VIRUS VECTOR; VP1 PROTEIN, POLIOVIRUS; VP2 PROTEIN, POLIOVIRUS;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; CHIMERA; CONTROLLED STUDY; GENE INSERTION; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLIOMYELITIS; STOP CODON; TOBACCO; TOBACCO MOSAIC VIRUS; VACCINE PRODUCTION; VIRUS CAPSID; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS RECOMBINATION; ANIMAL; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; PROTEIN ENGINEERING; TRANSGENIC PLANT; VIROLOGY;

HUMAN POLIOVIRUS 1; MIRIDAE; NICOTIANA TABACUM; POLIOVIRUS; TOBACCO MOSAIC VIRUS;

ANIMALS; CAPSID PROTEINS; GENETIC VECTORS; MICE; PLANTS, GENETICALLY MODIFIED; PROTEIN ENGINEERING; TOBACCO; TOBACCO MOSAIC VIRUS; TRANSFECTION;

EID: 33746741799     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.101.398     Document Type: Article

References (31)

1. Fischer R., and Emans N. Molecular farming of pharmaceutical proteins. Transgenic Res. 9 (2000) 279-299
2. Daniell H., Streatfield S.J., and Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 6 (2001) 219-226
3. Giddings G., Allison G., Brooks D., and Carter A. Transgenic plants as factories for biopharmaceuticals. Nat. Biotechnol. 18 (2000) 1151-1155
4. Fischer R., Liao Y.C., Hoffmann K., Schillberg S., and Emans N. Molecular farming of recombinant antibodies in plants. Biol. Chem. 380 (1999) 825-839
5. Fischer R., Hoffmann K., Schillberg S., and Emans N. Antibody production by molecular farming in plants. J. Biol. Regul. Homeost. Agents 14 (2000) 83-92
6. Mason H.S., Warzecha H., Mor T., and Arntzen C.J. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol. Med. 8 (2002) 324-329
7. Walmsley A.M., and Arntzen C.J. Plants for delivery of edible vaccines. Curr. Opin. Biotechnol. 11 (2000) 126-129
8. Yusibov V., Modelska A., Steplewski K., Agadjanyan M., Weiner D., Hooper D.C., and Koprowski H. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc. Natl. Acad. Sci. USA 94 (1997) 5784-5788
9. Goelet P., Lomonossoff G.P., Butler P.J.G., Akam M.E., Gait M.J., and Karn J. Nucleotide sequence of TMV RNA. Proc. Natl. Acad. Sci. USA 79 (1982) 5818-5822
10. Beachy R.N., and Zaitlin M. Characterization and in vitro translation of the RNAs from less-than-full-length, virus-related, nucleoprotein rods present in tobacco mosaic virus preparations. Virology 81 (1977) 160-169
11. Hunter T.R., Hunt T., Knowland J., and Zimmern D. Messenger RNA for the coat protein of tobacco mosaic virus. Nature 260 (1976) 759-764
12. Matthews R.E.F. Plant virology (1981), Academic Press, New York
13. Hamamoto H., Sugiyama Y., Nakagawa N., Hashida E., Matsunaga Y., Takemoto S., Watanabe Y., and Okada Y. A new tobacco mosaic virus vector and its use for the systemic production of angiotensin-I-converting enzyme inhibitor in transgenic tobacco and tomato. Bio/Technology 11 (1993) 930-932
14. Skuzeski J.M., Nichols L.M., Gesteland R.F., and Atkins J.F. The signal for a leaky UAG stop codon in several plant viruses includes the two downstream codons. J. Mol. Biol. 218 (1991) 356-373
15. Turpen T.H., Reinel S.J., Charoenvit Y., Hoffman S.L., and Fallarme V. Malarial epitopes expressed on the surface of recombinanat tobacco mosaic virus. Bio/Technology 13 (1995) 53-57
16. Sugiyama Y., Hamamoto H., Takemoto S., Watanabe Y., and Okada Y. Systemic production of foreign peptides on the particle surface of tobacco mosaic virus. FEBS Lett. 359 (1995) 247-250
17. Fitchen J., Beachy R.N., and Hein M.B. Plant virus expressing hybrid coat protein with added murine epitope elicits autoantibody response. Vaccine 13 (1995) 1051-1057
18. Staczek J., Bendahmane M., Gilleland L.B., Beachy R.N., and Gilleland Jr. H.E. Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa. Vaccine 18 (2000) 2266-2274
19. Wigdorovitz A., Filgueira D.M.P., Robertson N., Carrillo C., Sadir A.M., Morris T.J., and Borca M.V. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1. Virology 264 (1999) 85-91
20. Murray M.G., Kuhn R.J., Arita M., Kawamura N., Nomoto A., and Wimmer E. Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc. Natl. Acad. Sci. USA 85 (1988) 3203-3207
21. Hull H.F. The future of polio eradication. Lancet Infect. Dis. 1 (2001) 299-303
22. Andrus J.K., Thapa A.B., Withana N., Fitzsimmons J.W., Abeykoon P., and Aylward B. A new paradigm for international disease control: lessons learned from polio eradication in Southeast Asia. Am. J. Public Health 91 (2001) 146-150
23. Ehreth J. The global value of vaccination. Vaccine 21 (2003) 596-600
24. Buttinelli G., Ruggeri F.M., Marturano J., Novello F., Donati V., and Fiore L. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice. Virology 281 (2001) 265-271
25. Hogle J.M., Chow M., and Filman D.J. Three dimensional structure of poliovirus at 2.9 Å resolution. Science 229 (1985) 1358-1365
26. Filman D.J., Syed R., Chow M., Macadam A.J., Minor P.D., and Hogle J.M. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8 (1989) 1567-1579
27. Minor P.D., Ferguson M., Evans D.M.A., Almond J.W., and Icenogle J.P. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J. Gen. Virol. 67 (1986) 1283-1291
28. van der Werf S., Wychowski C., Bruneau P., Blondel B., Crainic R., Horodniceanu F., and Girard M. Localization of a poliovirus epitope type 1 neutralization epitope in viral capsid polypeptide VP1. Proc. Natl. Acad. Sci. USA 80 (1983) 5080-5084
29. Otsuki Y., Takebe I., Ohno T., Fukuda M., and Okada Y. Reconstitution of tobacco mosaic virus rods occurs bidirectionally from an internal initiation region: demonstration by electron microscopic serology. Proc. Natl. Acad. Sci. USA 74 (1977) 1913-1917
30. He Y., Bowman V.D., Mueller S., Bator C.M., Bella J., Peng X., Baker T.S., Wimmer E., Kuhn R.J., and Rossmann M.G. Interaction of the poliovirus receptor with polivirus. Proc. Natl. Acad. Sci. USA 97 (2000) 79-84
31. Lim A.A.L., Tachibana S., Watanabe Y., and Wong M.S. Expression and purification of a neuropeptide nocistatin using two related plant viral vectors. Gene 289 (2002) 69-79